tiprankstipranks
ABIONYX Pharma SA (GB:0RAG)
LSE:0RAG
Holding GB:0RAG?
Track your performance easily

ABIONYX Pharma SA (0RAG) Financial Statements

0 Followers

ABIONYX Pharma SA Financial Overview

ABIONYX Pharma SA's market cap is currently ―. The company's EPS TTM is €-0.105; its P/E ratio is -12.03; ABIONYX Pharma SA is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 4.03M€ 7.93M€ 4.83M€ 9.15M€ 8.81M
Total Assets€ 18.18M€ 21.83M€ 7.18M€ 10.29M€ 9.21M
Total Debt€ 4.49M€ 4.96M€ 165.00K€ 24.00K€ 1.15M
Net Debt€ 465.00K€ -2.98M€ -4.67M€ -9.13M€ -7.66M
Total Liabilities€ 9.53M€ 11.15M€ 3.12M€ 3.66M€ 3.45M
Stockholders Equity€ 8.64M€ 10.68M€ 4.06M€ 6.63M€ 5.76M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History

ABIONYX Pharma SA Debt to Assets

ABIONYX Pharma SA Cash Flow

ABIONYX Pharma SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis